We are excited to announce that ExecMind just started a collaboration with Biobohemia, an American innovative biotech company based in Cambridge, MA.
The company is working to develop a new type of cancer vaccine using proteomics and a novel antigen composition for anticancer vaccination.
Cancer vaccine development technologies have been expanded with ANTIGENIC ESSENCE technology which makes it possible to enhance cellular vaccines that have already been developed, as well as to develop new ones, therefore introducing a new direction for anticancer vaccination.


You can learn more here: